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The baculovirus Autographa californica nuclear polyhedrosis virus encodes a DNA-dependent RNA polymer-
ase that is required for transcription of viral late genes. This polymerase is composed of four equimolar sub-
units, LEF-8, LEF-4, LEF-9, and p47. The LEF-4 subunit has guanylyltransferase activity, suggesting that
baculoviruses may encode a full complement of capping enzymes. Here we show that LEF-4 is a bifunctional enzyme
that hydrolyzes the gamma phosphates of triphosphate-terminated RNA and also hydrolyzes ATP and GTP to
the respective diphosphate forms. Alanine substitution of five residues previously shown to be essential for vac-
cinia virus RNA triphosphatase activity inactivated the triphosphatase component of LEF-4 but not the guan-
ylyltransferase domain. Conversely, mutation of the invariant lysine in the guanylyltransferase domain abol-
ished the guanylyltransferase activity without affecting triphosphatase function. We also investigated the effects
of substituting phenylalanine for leucine at position 105, a mutation that results in a virus that is temperature
sensitive for late gene expression. We found that this mutation had no significant effect on the ATPase or
guanylyltransferase activity of LEF-4 but resulted in a modest decrease in RNA triphosphatase activity.
Expression of baculovirus genes in infected cells is tempo-
rally regulated at the transcriptional level. Immediately after
infection, only a subset of viral genes is expressed. These im-
mediate-early genes are transcribed by host RNA polymerase
II (pol II) and do not require the action of viral transcription
factors (6, 11, 16, 31). Expression of IE1 during this stage
allows for the transcription of the delayed-early class of genes
which are also transcribed by pol II (10, 19, 43). IE1 binds to
viral enhancer elements and presumably helps to recruit host
pol II to the early promoters (9). Many delayed-early genes
encode proteins required for viral DNA replication and late
gene expression, and expression of these proteins sets the stage
for late gene expression. The late and very late genes are
transcribed by an RNA polymerase that is resistant to a-aman-
itin and is chromatographically distinct from the three host
RNA polymerases (6, 42).
Recently we purified the virus-specific RNA polymerase and
showed that it was composed of four subunits, all of which are
virus encoded (13). This finding raises interesting questions
regarding the mechanisms of posttranslational processing of
late viral mRNAs. Both late and very late transcripts are
capped at the 59 ends with a typical 7-methylguanosine (m7G)
structure (32). It has been shown in other systems that these
mRNA caps are added cotranscriptionally when nascent RNAs
are less than 30 nucleotides in length (1). Only mRNAs are
capped, and this restriction is mediated by specific interactions
of capping enzymes with their cognate RNA polymerases (4,
24). This model suggests that either the baculovirus RNA
polymerase must interact with host capping enzymes or the
baculoviruses must encode their own capping enzymes.
The accompanying report (12) provides a partial answer to
this question with its demonstration that the LEF-4 subunit of
Autographa californica nuclear polyhedrosis virus (AcNPV)
RNA polymerase has guanylyltransferase activity. Further-
more, analysis of the LEF-4 amino acid sequence revealed the
presence of a conserved KxDG motif and homology to five
additional motifs that are common to viral and cellular guany-
lyltransferases, which strongly supports our enzymatic data.
Guanylyltransferase is one of the three enzymatic functions
required for the formation of a m7G cap on the 59 ends of
mRNAs. The other two enzymes needed are RNA triphos-
phatase, which removes the gamma phosphate from 59 triphos-
phate termini, and RNA methyltransferase, which adds a
methyl group to the N-7 position of the guanosine cap. Vac-
cinia virus encodes a multifunctional capping enzyme that cat-
alyzes all three steps (15, 22, 23), which suggested to us that
LEF-4 may also have additional functions. In support of this
hypothesis, we noticed sequence similarities between the bac-
ulovirus LEF-4 proteins and residues previously shown to be
essential for triphosphatase function of the vaccinia virus cap-
ping enzyme. Here we report that LEF-4 has RNA triphos-
phatase activity. Furthermore, we show that mutation of these
conserved residues abrogates the triphosphatase function of
LEF-4.
MATERIALS AND METHODS
Purification of RNA polymerase and in vitro transcription assays. RNA poly-
merase was purified from Spodoptera frugiperda cells infected with vBAC-RNA
pol as previously described (13). In vitro transcription assays were performed as
described by Xu et al. (41).
Construction of LEF4-intein clones. The AcNPV genomic clone pHindIII-C
was amplified by using Pfu I DNA polymerase. The 59 primer (CTGCAGCCA
TGGACTACGGCGATTTTGTG) inserted an NcoI site (underlined) at the
ATG codon of LEF-4. The 39 primer (TTACCCGGGCACGATTCGGTCGCG)
was designed to substitute a glycine residue for the C-terminal aspartate and
added a SmaI site (underlined) at the C-terminal glycine. The PCR products
were cloned into pBluescript and screened by restriction enzyme digestion. A
clone containing LEF-4 was digested with NcoI and SmaI and ligated to pCYB4
(New England Biolabs) previously digested with NcoI and SmaI. This plasmid
directs the synthesis of a fusion protein containing a self-cleavable affinity tag
under control of the tac promoter. Recombinant DNAs were screened by re-
striction enzyme digestion, and a clone with the correct size insert was se-
quenced. Alanine substitution mutations in LEF-4 were constructed by using a
QuikChange site-directed mutagenesis kit (Stratagene) as recommended by the
manufacturer. Potential mutant clones were verified by DNA sequence analysis.
Purification of LEF-4 from bacteria. Escherichia coli XL1-Blue cells contain-
ing pLEF4-intein were grown to late log phase, and expression of LEF-4 was
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induced by the addition of 0.4 mM 5-bromo-4-chloro-3-indolyl-b-D-galactopy-
ranoside. After induction, cells were incubated at 20°C overnight. Cells were
harvested by centrifugation, resuspended in buffer B (50 mM Tris [pH 7.9], 0.1
mM EDTA, 500 mM NaCl, 0.1% Triton X-100), lysed by sonication, and clarified
by low-speed centrifugation. The resulting supernatant was loaded onto a 2-ml
chitin column. The column was washed with 20 volumes buffer B plus 30 mM
dithiothreitol (DTT) and allowed to sit overnight in the presence of 30 mM DTT.
Cleaved LEF-4 was eluted with 3 column volumes of buffer B plus 30 mM DTT.
Sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE) fol-
lowed by staining with Coomassie brilliant blue showed a single protein that
migrated in the expected position for LEF-4. LEF-4 was further purified by
anion-exchange chromatography. Peak fractions were dialyzed against buffer A
(50 mM Tris [pH 7.9], 0.1 mM EDTA, 1 mM DTT) containing 50 mM NaCl, and
the protein was applied to a Mono Q HR 5/5 column (Pharmacia) previously
equilibrated in the same buffer. The column was washed with 10 ml of loading
buffer and then eluted with a 20-ml linear NaCl gradient from 50 to 500 mM.
LEF-4 eluted from Mono Q in a single sharp peak at 230 mM NaCl. LEF-4 was
quantitated by a Coomassie blue G250 binding assay performed as recom-
mended by the manufacturer (Pierce).
Assay of LEF-4–GMP complex formation. Standard reaction mixtures (25 ml)
contained 50 mM Tris-HCl (pH 7.9), 1 to 5 mM MnCl2, 5 mM DTT, 5 mM
[a-32P]GTP, and purified RNA polymerase or LEF-4 as indicated. Samples were
incubated for 15 min at 30°C and then stopped by the addition of 1% SDS.
Samples were boiled and electrophoresed through an SDS–8% polyacrylamide
gel. Gels were fixed, dried, and exposed to film.
RNA triphosphatase assays. RNA 59-triphosphatase activity was assayed by
the liberation of [32P]Pi from [g-32P]GTP-terminated RNA. Template RNA was
synthesized by in vitro transcription of pBluescript KS DNA previously digested
with BssHII. The linearized template was transcribed with T3 RNA polymerase,
using standard conditions for in vitro transcription in the presence of [g-32P]GTP
added at a final specific activity of 5,000 cpm/pmol. This produced a 150-nucle-
otide-long RNA transcript specifically labeled at the 59 end. g-32P-labeled RNA
was purified from transcription reactions by three rounds of precipitation with
2.5 M LiCl, followed by standard ethanol precipitation. Standard RNA triphos-
phatase assay mixtures (20 ml) contained 50 mM Tris-HCl (pH 7.9), 5 mM DTT,
0.3 mM MnCl2, 50 mM KCl, 1 to 5 mM RNA, and enzyme as indicated. Reac-
tions were incubated for 15 min at 30°C and then terminated by the addition of
1 M formic acid. Samples were applied to polyethylenimine (PEI)-cellulose
thin-layer chromatography (TLC) plate (J. T. Baker) and chromatographed with
0.5 M KH2PO4 (pH 3.4). Reactions were quantitated by scanning the TLC plate
in a FUJIX BAS PhosphorImager.
ATPase assays. Standard reaction mixtures (20 ml) contained 50 mM Tris-HCl
(pH 7.9), 5 mM DTT, 50 mM KCl, 0.3 mM MnCl2, 1 mM [g-32P]ATP or GTP,
and enzyme as indicated. Reactions were incubated 15 min at 30°C, and aliquots
were spotted on PEI-cellulose plates. Reactions were quantitated by scanning the
plates with a PhosphorImager.
RESULTS
RNA triphosphatase activity of RNA polymerase and puri-
fied LEF-4. We have previously shown that the LEF-4 subunit
of AcNPV RNA polymerase has guanylyltransferase activity,
suggesting that LEF-4 is an RNA capping enzyme (12). Fur-
thermore, analysis of the LEF-4 amino acid sequence revealed
homology to six motifs that are shared among viral and cellular
guanylyltransferases in the C-terminal half of the protein. Se-
quence analysis of the N-terminal portion of LEF-4 revealed
homologies with the triphosphatase domains of capping en-
zymes in the poxviruses and African swine fever virus (Fig. 1).
Two pairs of glutamic acid residues and a single arginine have
been shown to be essential for the RNA triphosphatase and
ATPase activities of vaccinia virus capping enzyme (45). These
glutamates and arginines are present in AcNPV LEF-4 with a
similar order and spacing as found in the vaccinia virus and
African swine fever virus capping enzymes. Furthermore, these
residues are conserved among all three of the baculovirus
LEF-4 proteins that have been submitted to protein and nu-
cleic acid databases. These similarities suggested to us that the
LEF-4 subunit of baculovirus RNA polymerase may have
RNA triphosphatase and ATPase activities in addition to gua-
nylyltransferase function.
To test this hypothesis, purified AcNPV RNA polymerase
was filtered through Superose 6 (Fig. 2A). As previously shown
(12), a peak of guanylyltransferase activity coincided with the
peak of absorbance at 280 nm and the peak of polymerase
activity (Fig. 2B). To test for RNA triphosphatase activity,
g-32P-labeled RNA was prepared by in vitro transcription with
T3 RNA polymerase in the presence of [g-32P]GTP. This pro-
duces an RNA transcript that is singly labeled in the gamma
phosphate position at the 59 end of the RNA. RNA polymerase
fractions were then incubated with 1 mM [g-32P]RNA in the
presence of 1 mM MnCl2. After incubation for 15 min at 30°C,
free phosphate was separated from the RNA substrate by TLC
on PEI-cellulose. As shown in Fig. 2B, RNA polymerase frac-
tions catalyzed the hydrolysis of gamma phosphates from the
RNA substrate. Furthermore, the extent of cleavage was pro-
portional to input protein, and the peak of RNA triphos-
phatase activity exactly matched the peak of transcription ac-
tivity. This finding indicates that RNA triphosphatase is an
integral component of the baculovirus RNA polymerase.
To examine the specificity of the triphosphatase activity,
fractions were also incubated with [g-32P]ATP, and the release
of free phosphate was monitored by PEI chromatography. The
peak of activity of gamma phosphate release exactly coincided
with the three other enzymatic functions analyzed (Fig. 2B).
Essentially identical results were obtained with [g-32P]GTP as
the substrate (data not shown). This finding suggests that the
baculovirus enzyme, like the vaccinia virus capping enzyme,
has nucleoside triphosphatase activity in addition to RNA
triphosphatase activity.
Triphosphatase activity of purified LEF-4. To demonstrate
that the RNA triphosphatase and ATPase activities were due
to LEF-4 and not to other components of the RNA polymer-
ase, purified LEF-4 was also assayed for both activities (Fig. 3).
LEF-4 was overexpressed in baculovirus-infected cells and pu-
rified to near homogeneity by heparin-agarose and Mono Q
chromatography as previously described (12). Purified LEF-4
was then filtered through a Superdex 200 gel exclusion column.
Fractions corresponding to the peak of UV absorbance were
assayed for guanylyltransferase activity, using the GMP label
transfer assay. The same fractions were also active in the RNA
triphosphatase and ATPase assays. The specific activities of the
FIG. 1. Sequence of the LEF-4 RNA triphosphatase domain. The amino acid
sequence of the AcNPV LEF-4 from residues 1 to 194 is aligned with the LEF-4
sequences of Bombyx mori nuclear polyhedrosis virus (BmNPV) and Orgyia
pseudotsugata nuclear polyhedrosis virus (OpNPV) and the N-terminal regions of
the capping enzymes of vaccinia virus (VAC) and African swine fever virus
(ASF). Gaps in the sequence alignment are denoted by hyphens; residues that
are identical in at least four of the five sequences are shown in bold; residues
shown to be essential for RNA triphosphatase activity in vaccinia virus are
indicated by asterisks above the sequence (44). Leucine 105 (underlined) is
substituted with a phenylalanine in the LEF-4 ts virus.










three enzymatic functions were nearly constant across the peak
of protein. This result is consistent with our hypothesis that the
triphosphatase and ATPase activities of RNA polymerase map
to the LEF-4 subunit.
Characterization of the RNA triphosphatase component of
LEF-4. The RNA triphosphatase activity of LEF-4 was abso-
lutely dependent on the addition of a divalent cation (Fig. 4A).
Manganese was a more efficient cofactor than was magnesium
at all concentrations tested. Activity peaked sharply at 0.3 mM
and declined at higher concentrations. Magnesium was active
over a broader range and was maximal at 1 mM, at which
concentration the activity was 30% of that achieved with man-
ganese. Essentially the same results were seen with RNA poly-
merase (data not shown).
Under optimal conditions, the extent of gamma phosphate
hydrolysis during a 15-min incubation was proportional to in-
put protein with both sources of enzyme (Fig. 4B). In the linear
range of enzyme concentration, the turnover number for RNA
polymerase was 0.16 fmol/s/fmol of enzyme, while that of LEF-
4 was 0.31 fmol/s/fmol.
Characterization of the nucleoside triphosphatase compo-
nent of LEF-4. Hydrolysis of ATP was also absolutely depen-
dent on the addition of a divalent cation (Fig. 5A). In the pres-
ence of manganese, ATPase activity increased linearly from
0.08 to 0.6 mM and then declined slowly at higher concentra-
tions. Magnesium was a poor substitute for manganese, unlike
the results observed for magnesium in the RNA triphosphatase
assays. The ATPase activity at 10 mM magnesium was only 1%
of the maximal activity gained with manganese.
Specificity for the gamma phosphate was monitored by using
[a-32P]GTP as the substrate (Fig. 5B). GDP accumulated lin-
early at a rate of 6.4 pmol/min/pmol of enzyme. GDP was slow-
ly converted to GMP at a rate of 0.22 pmol/min/pmol of en-
zyme. Free phosphate was not detected during the 30-min time
course.
Structure-function analysis of LEF-4. To confirm that the
RNA triphosphatase and ATPase activities observed were attrib-
utable to LEF-4, we expressed three mutated versions of LEF-
4. Four glutamates and one arginine corresponding to residues
previously shown to be essential for vaccinia virus triphospha-
FIG. 2. RNA triphosphatase and ATPase activities of baculovirus RNA poly-
merase. (A) Gel filtration chromatography of RNA polymerase. RNA polymer-
ase was filtered through Superose 6 as previously described (13). OD280, optical
density at 280 nm. (B) In vitro transcription. Fractions corresponding to the peak
of absorbance at 280 nm were assayed for in vitro transcription. The positions of
molecular size markers are shown in kilodaltons on the left. The radiolabeled
products corresponding to initiation from the polyhedrin (polh/CFS) and 39k
(39k/CFS) promoters are shown on the right. (C) Guanyltransferase, RNA
triphosphatase (RTPase), and ATPase assays. Guanylyltransferase mixtures (25
ml) contained 50 mM Tris HCl (pH 7.9), 5 mM DTT, 1 mM [a-32P]GTP, 1 mM
MnCl2, and 2 ml of each fraction. Reactions were incubated at 30°C for 15 min,
stopped by the addition of 1% SDS, and separated on an 8% polyacrylamide gel.
RNA triphosphatase mixtures (10 ml) contained 50 mM Tris HCl (pH 7.9), 5 mM
DTT, 1 mM MnCl2, 1 mM (59 termini) g-32P-labeled RNA, and 0.2 ml of each
fraction. Reactions were incubated at 30°C for 15 min, stopped by the addition
of 1 M formic acid, spotted on PEI-cellulose plates, and quantitated by scanning
in a PhosphorImager. Picomoles of phosphate released is plotted on the right.
ATPase mixtures (10 ml) contained 50 mM Tris HCl (pH 7.9), 5 mM DTT, 1 mM
MnCl2, 1 mM [g-32P]ATP, and 0.2 ml of each fraction. , EpG; v and M, Pi
released. FIG. 3. RNA triphosphatase and ATPase activities of LEF-4. LEF-4 was
purified by recombinant baculovirus-infected cells and filtered through Superdex
200 as previously described (12). Fractions corresponding to the peak of absor-
bance at 280 nm were assayed for guanylyltransferase, RNA triphosphatase
(RTPase), and ATPase activities as described in the legend to Fig. 2. Guanylyl-
transferase activity is plotted on the left; picomoles of phosphate released from
gamma-labeled RNA or ATP is plotted on the right. , EpG; v and M, Pi
released.










tase activity (45) were changed to alanine. We also expressed a
mutant protein in which the lysine residue of the guanylyltrans-
ferase KxDG motif was substituted with alanine. For ease of
expression and purification, the mutant LEF-4 proteins were
expressed in the E. coli expression system IMPACT I (New
England Biolabs). This system produces fusion proteins with a
self-cleavable intein tag linked to a chitin-binding domain.
Cleavage of the intein tag produces a protein that is identical
to the wild-type LEF-4 except for the substitution of a glycine
residue for the C-terminal asparagine. This substitution does
not affect the enzymatic activities of the protein, as all of our
assays indicated that LEF-4 produced in E. coli was equivalent
to native LEF-4 purified from baculovirus-infected cells (Fig. 6
and data not shown).
After elution from the intein column, the LEF-4 protein
samples were further purified by Mono Q chromatography.
Figure 6 shows that the wild-type and mutant proteins ex-
pressed in E. coli were purified to single-band homogeneity.
FIG. 4. Characterization of the RNA triphosphatase activity of LEF-4. (A) Cation requirements. Reaction mixtures contained 50 mM Tris HCl (pH 7.9), 5 mM
DTT, 1 mM (59 termini) g-32P-labeled RNA, 0.1 pmol of LEF-4, and divalent cation as indicated in 20 ml. Reactions were incubated at 30°C for 15 min, spotted on
PEI-cellulose plates, and quantitated by scanning in a PhosphorImager. Picomoles of phosphate released is plotted as a function of magnesium or manganese
concentration. (B) Protein titration. Reaction mixtures (20 ml) contained 50 mM Tris HCl (pH 7.9), 5 mM DTT, 1 mM g-32P-labeled RNA, 0.3 mM MnCl2, and AcNPV
RNA polymerase or LEF-4 purified from baculovirus-infected insect cells as indicated. Picomoles of phosphate released is plotted as a function of input protein.
FIG. 5. Characterization of the nucleoside triphosphatase activity of LEF-4. (A) Cation requirements. Reaction mixtures contained 50 mM Tris HCl (pH 7.9), 5
mM DTT, 1 mM [a-32P]ATP, 0.2 pmol of LEF-4 purified from baculovirus-infected cells, and divalent cation as indicated in 20 ml. Reactions were incubated at 30°C
for 15 min, spotted on PEI-cellulose plates, and quantitated by scanning in a PhosphorImager. Picomoles of phosphate released is plotted as a function of magnesium
or manganese concentration. (B) Phosphate specificity. Reaction mixtures contained 50 mM Tris HCl (pH 7.9), 5 mM DTT, 1 mM [a-32P]GTP, 0.3 mM MnCl2 and
0.2 pmol of LEF-4 purified from baculovirus-infected cells in 20 ml. Picomoles of GDP or GMP produced is plotted as a function of input protein.










Guanylyltransferase assays were performed to ensure that the
mutant proteins were correctly folded. The specific activities of
the mutant and wild-type enzymes were determined within the
linear range of enzymatic activity. With the wild-type enzyme,
0.5% of the available binding sites were radiolabeled, compa-
rable to the level observed with native LEF-4 produced in
baculovirus-infected cells (12). The activities of the triphos-
phatase mutants were equivalent to that of the wild-type pro-
tein, with the exception of that of E9/11A, which was 2.5-fold
higher than the activity of the wild-type protein. As expected,
the guanylyltransferase activity of the K255A mutant was un-
detectable. It has been established in other systems that nucle-
otidyltransferases form covalent intermediates with adenylate
or guanylate linked to the lysine residue of the KxDG motif (5,
25). Thus, analysis of this mutation serves to demonstrate that
the guanylyltransferase and triphosphatase activities are local-
ized to separate domains.
RNA triphosphatase activities of the mutant and wild-type
enzymes were assayed by release of 32Pi from 1 mM [g-
32P]
RNA. The wild-type protein hydrolyzed 210 pmol of Pi per
pmol of protein in a 15-min incubation. The specific activities
of the mutant proteins relative to wild type are shown in Table
1. RNA triphosphatase activity was undetectable in the E181/
183A mutant, reduced 100-fold in the E9/11A mutant, and
reduced to 2.5% of control levels in the R51A mutant. ATPase
activities were assayed by release of 32Pi from 1 mM [g-
32P]
ATP. The wild-type enzyme liberated 108 pmol of Pi per mol
of LEF-4 in 15 min at 30°C. The activity of all three mutants
was reduced to less than 1% of that of the control. The K255A
mutant retained both RNA triphosphatase and ATPase activ-
ities. These data are consistent with results obtained with cor-
responding mutations in the vaccinia virus capping enzyme
(44).
Analysis of the L105F LEF-4 mutant. The lef-4 gene was first
described as the site of a mutation in a virus that was temper-
ature sensitive (ts) for expression of late genes (28). The ts
lesion in LEF-4 was mapped to a single-nucleotide transver-
sion resulting in a substitution of phenylalanine for leucine at
amino acid residue 105 (3), within the RNA triphosphatase
domain (Fig. 1). This finding suggested the possibility that the
defect in late gene expression may be due to incomplete hy-
drolysis of the gamma phosphates of late transcripts and there-
fore inefficient capping of late transcripts. One function of the
m7G cap is to protect mRNAs from degradation. Therefore, a
defect in capping could lead to rapid turnover of late mRNAs,
producing the phenotype observed in this mutant.
To characterize the L105F mutation, we expressed a mutant
protein with this substitution as described above for the alanine
substitutions. The protein was expressed at 20°C and tested for
guanylyltransferase, RNA triphosphatase, and ATPase activi-
ties at 25 and 33°C. As shown in Fig. 7A, the purity of the
L105F protein was commensurate with that of the wild-type
protein. Guanylyltransferase activities were also equivalent to
those of the wild-type protein at both permissive and nonper-
missive temperatures. With both mutant and wild-type pro-
teins, the activity was slightly higher at 25 than at 30°C, while
the activity was reduced by half at the higher temperature (Fig.
7B). The wild-type protein bound GMP to an extent that oc-
cupied 0.7% of available sites at 25°C and only 0.2% at 33°C.
The activity of the mutant protein was approximately 85% that
of the wild type at both temperatures. These data indicate that
substitution of the phenylalanine for leucine did not lead to
temperature-dependent unfolding of LEF-4.
The RNA triphosphatase and ATPase activities of L105F
were determined by protein titration at the permissive and non-
permissive temperatures. Both activities were indistinguishable
from that of the wild-type protein at the permissive tempera-
ture (Table 2). At the nonpermissive temperature, the ATPase
activity of the ts mutant was equivalent to wild-type activity but
FIG. 6. Purification and guanylyltransferase activities of LEF-4 mutants. (A)
SDS-PAGE analysis of wild-type (wt) and mutant (E9/11A, R51A, K255A, and
E181/183A) proteins purified from bacteria. Protein (1.35 mg per lane) purified
by Mono Q chromatography was analyzed on SDS–8% polyacrylamide gels. The
migration of prestained molecular markers is indicated on the left. (B) Guanyl-
yltransferase assays. Guanylyltransferase activities were measured by formation
of a covalent enzyme-GMP complex. Reaction mixtures (25 ml) contained 50
mM Tris (pH 7.9), 5 mM DTT, 5 mM MnCl2, 1 mM [32P]GTP, and 0.1 mg of the
indicated protein. Reactions were stopped by the addition of 1% SDS and
electrophoresed through an SDS–8% polyacrylamide gel. The positions of 14C-
labeled protein markers are shown in kilodaltons on the left. The position of
LEF-4 is indicated on the right.
TABLE 1. Mutational effects of alanine substitutions on
guanylyltransferase, RNA triphosphatase, and
ATPase activities of LEF-4a
Mutant
Sp act (% of wild-type activity)
Guanylyltransferase RTPase ATPase
E9/11A 78 1.5 0.8
R51A 80 2.5 ,0.2
E181/183A 79 ,0.01 ,0.3
K256A ,0.01 84.6 98.1
a Wild-type and mutant proteins were purified by affinity and anion-exchange
chromatography and then titrated for guanylyltransferase, RNA triphosphatase
(RTPase), and ATPase activities as described in Materials and Methods. Specific
activities were determined in the linear range of enzyme dependence. Two
independent enzyme preparations were tested for each protein, and each prep-
aration was tested in duplicate or triplicate. Values represent averages of all
determinations.










the RNA triphosphatase activity was reduced to 74% of the
wild-type level. Mutational analyses of the vaccinia virus cap-
ping enzyme indicate that the RNA triphosphatase and ATPase
activities map to the same active site (25, 44), and the data
presented in Table 1 suggest that both activities of LEF-4 also
colocalize. Therefore, it is possible that this residue maps to an
RNA binding site rather than to the catalytic site. However,
this effect is minimal and unlikely to account for the ts pheno-
type observed for the LEF-4 mutant virus.
Thermal stability of L105F. To further investigate the activ-
ities of L105F at the nonpermissive temperature, thermal in-
activation profiles for the three enzymatic activities were pro-
duced (Fig. 8). Wild-type and L105F proteins were incubated
at the permissive (25°C) or nonpermissive (33°C) temperature
for defined lengths of time and then tested for guanylyltrans-
ferase and triphosphatase activities at the nonpermissive tem-
perature. In addition, we analyzed the effect of preincubation
at 37°C, which is higher than the nonpermissive temperature in
vivo.
The temperature inactivation profile for the guanylyltrans-
ferase activities indicated that both wild-type and mutant en-
zymes were sensitive to incubation at elevated temperatures
(Fig. 8A). After 30 min at 37°C, the activity of the wild-type
enzyme was reduced to 1% of control levels (no preincuba-
tion). Incubation for 30 min at 33 or at 25°C reduced activity to
approximately 20% of control levels. At 25 and 33°C, the
inactivation profiles of the L105F mutant mirrored those of the
wild type, and the values averaged 87% of wild-type values. At
37°C, the difference between the two proteins was greater. The
activity of L105F was averaged 50% of that of the wild type
after incubation at 37°C.
ATPase profiles were similar for the wild type and L105F.
The activities of both enzymes in ATPase assays decreased
approximately 50% after 30 min of preincubation at 25°C, 56%
at 33°C, and 74% at 37°C. RNA triphosphatase activities
showed the highest level of thermal stability for both proteins.
The inactivation profiles for L105F and the wild type were
indistinguishable at 25 and 33°C, with both enzymes losing only
10% of their activities after 30 min of preincubation. L105F
was somewhat more sensitive than the wild type to incubation
at 37°C and retained only 60% of its activity after 30 min, while
the wild-type enzyme retained 78% of its activity.
DISCUSSION
Eukaryotic viruses that replicate in the cytosol have evolved
diverse strategies to ensure that their mRNAs are capped (2).
RNA viruses either steal their caps from cellular mRNAs,
encode their own capping enzymes, or circumvent the need for
a cap by including elements in their RNAs that promote cap-
independent translation. Poxviruses and African swine fever
virus encode their own capping and methylating enzymes,
while most other DNA viruses replicate in the nucleus and rely
on host capping enzymes. Here we present data showing that
baculoviruses have provided yet another solution to the cap-
ping problem. They replicate in the nucleus yet still encode at
least two of the enzymes required for cap formation. More-
over, these enzymatic functions are incorporated into the bac-
ulovirus RNA polymerase.
In the accompanying report, we present data suggesting that
LEF-4 is a guanylyltransferase (12). Analysis of the LEF-4
amino acid sequence revealed homology to five collinear mo-
tifs that are shared among viral and cellular guanylyltrans-
ferases (40), confirming the enzymatic data. These motifs are
localized to the C-terminal half of the protein. Here we show
that the N-terminal portion of the molecule shows local se-
quence conservation with the triphosphatase domain of vac-
cinia virus capping enzyme. Five residues in the vaccinia en-
zyme were previously shown to be required for ATPase and
RNA triphosphatase activities (45). These amino acids are
conserved among all of the baculovirus LEF-4 proteins in the
FIG. 7. Characterization of the L105F protein. (A) SDS-PAGE analysis of
wild-type (wt) and L105F mutant LEF-4 proteins purified from bacteria. Protein
(1 mg per lane) purified by Mono Q chromatography was analyzed on SDS–8%
polyacrylamide gels. The migration of prestained molecular markers is indicated
in kilodaltons on the left. (B) Guanylyltransferase assays. Guanylyltransferase
activities were measured by formation of a covalent enzyme-GMP complex.
Reactions mixtures (25 ml) contained 50 mM Tris (pH 7.9), 5 mM DTT, 5 mM
MnCl2, 1 mM [32P]GTP, and 0.1 mg of the indicated protein. Reactions were
incubated for 15 min at 25°C (lanes 2 and 4) or 33°C (lanes 3 and 5), stopped by
the addition of 1% SDS, and electrophoresed through an SDS–8% polyacryl-
amide gel. The positions of 14C-labeled protein markers are shown in kilodaltons
on the left. The migration of LEF-4 is indicated on the right.
TABLE 2. Specific activities of L105F at the permissive
and nonpermissive temperaturesa
Enzyme assay
Sp act (% of wild-type activity)
25°C 33°C
Guanylyltransferase 85 83
RNA triphosphatase 98 74
ATPase 103 93
a Wild-type LEF-4 and L105F were purified by affinity and anion-exchange
chromatography and then titrated for guanylyltransferase, RNA triphosphatase,
and ATPase activities as described in Materials and Methods. Specific activities
were determined in the linear range of enzyme dependence. Two independent
enzyme preparations were tested for each protein, and each preparation was
tested in duplicate or triplicate. Values represent averages of all determinations.










same order and with similar spacing, suggesting that LEF-4
was also a triphosphatase.
We demonstrated that both RNA 59-triphosphatase and
ATPase activities copurified with the guanylyltransferase and
transcription activities of AcNPV RNA polymerase. The spe-
cific activities of the four enzymes were essentially linear across
the peak of protein, strongly suggesting that all four enzymes
were contained within the same protein complex. Moreover,
we showed that the RNA triphosphatase and ATPase activities
coeluted, with the peak of LEF-4 protein when overexpressed
as a single subunit. Further confirmation was provided by mu-
tagenesis data showing that substitution of alanine at critical
residues abrogated the triphosphatase and ATPase activities of
LEF-4.
RNA 59-triphosphatase is required for the hydrolysis of gam-
ma phosphates from primary transcripts which have triphos-
phate termini. The resultant diphosphate-terminated RNAs serve
as acceptors for the guanylyltransferase reaction in the produc-
tion of GpppN caps on the ends of RNAs. Although we have
not demonstrated that LEF-4 is capable of transferring GMP
to diphosphate-terminated RNAs, it seems reasonable to pro-
pose that the function of LEF-4 is to cap RNAs transcribed by
the baculovirus RNA polymerase.
Gross and Shuman (8) have recently demonstrated that
AcNPV encodes another protein with RNA 59-triphosphatase
function. This protein, protein tyrosine phosphatase (PTPase),
was originally identified on the basis of sequence homology
with protein tyrosine/serine phosphatases (18, 36), and it was
shown to be active in the hydrolysis of phosphotyrosine- and
phosphoserine-containing substrates. However, the identifica-
tion of a Caenorhabditis elegans RNA 59-triphosphatase with a
protein tyrosine/serine signature motif suggests that RNA may
be the preferred substrate for some members of this family
(37). Indeed, Gross and Shuman showed that PTPase hydro-
lyzed RNA substrates at a rate several orders of magnitude
higher than that reported for protein substrates. Thus, it seems
likely that this protein functions as an RNA 59-triphosphatase
and not a protein phosphatase. However, ptpase is not essential
for viral replication and is not required for the transient ex-
pression of late and viral late genes, while lef-4 is required for
both transient expression and productive viral infection (3, 20,
38). Furthermore, LEF-4 is part of the RNA polymerase com-
plex and so is optimally positioned to serve as the primary
protein involved in hydrolysis of primary termini of baculovirus
late mRNAs.
The function of the ATPase activity of LEF-4 is unknown, as
is the role of the ATP hydrolysis of the vaccinia virus capping
enzyme. Vaccinia virus capping enzyme is also required for
transcription termination, and early experiments suggested
that the ATPase activity of vaccinia virus capping enzyme was
required for transcription termination (14). However, recent
alanine mutagenesis experiments showed that capping en-
zymes which are deficient in ATP hydrolysis are still active
in promoting transcription termination (45). As yet, nothing is
known regarding the mechanisms of transcription termination
in the baculovirus system. Development of a termination assay
FIG. 8. Thermal stability of LEF-4 L105F. (A) Guanylyltransferase assays.
Guanylyltransferase activities were measured by formation of a covalent enzyme-
GMP complex. Reactions mixtures (25 ml) contained 50 mM Tris (pH 7.9), 5 mM
DTT, 5 mM MnCl2, 5 mM [32P]GTP, and 0.01 mM wild-type (WT) or L105F
protein. After incubation in the absence of GTP for the indicated times at 25, 33,
or 37°C, the samples shifted to 25°C, GTP was added, and the samples were
incubated for 15 min. Reactions were quantitated by scanning of SDS-protein
gels in a PhosphorImager. EpG, LEF-4. (B) ATPase assays. Reaction mixtures
(20 ml) contained 50 mM Tris HCl (pH 7.9), 5 mM DTT, 1 mM [g-32P]ATP, 0.3
mM MnCl2 and 0.01 mM of wild-type or L105F protein. (C) RNA triphosphatase
assays. Reaction mixtures (20 ml) contained 50 mM Tris HCl (pH 7.9), 5 mM
DTT, 1 mM g-32P-labeled RNA, 0.3 mM MnCl2, and 5 nM of wild-type or L105F
protein. Samples for RNA triphosphatase and ATPase activities were incubated
for the indicated amounts of time at 25, 33, or 37°C in the absence of substrate;
then the samples were shifted to 25°C, RNA or ATP was added, and the samples
were incubated for 15 min. Reactions were quantitated by scanning TLC plates
in a PhosphorImager. Each point represents the average of triplicate reactions.










will be essential in determining whether LEF-4 is involved in
termination as well as capping of viral RNAs.
The ts mutation previously mapped to the lef-4 gene results
in a substitution of phenylalanine for leucine at position 105
(3). The phenotype of this mutant is consistent with a defect in
late gene expression, as it is characterized by decreased num-
bers of virions and decreased levels of late gene expression.
L105 is located in the triphosphatase domain; therefore, we
considered the possibility that the ts phenotype was due to a
defect in mRNA capping. The mRNA cap plays essential roles
in mRNA stability and initiation of translation. Thus, it seemed
possible that production of uncapped RNAs could result in
decreased translation of viral structural proteins due to rapid
turnover of late RNAs. Bombyx mori and Orgyia pseudotsugata
nuclear polyhedrosis viruses have leucine or valine at this po-
sition; thus, there is some sequence conservation among the
baculoviruses at L105. To address this question, we produced
a mutant LEF-4 protein with a phenylalanine at residue 105.
The enzymatic activities of wild-type protein and L105F were
compared by protein titration experiments at permissive and
nonpermissive temperatures. We found that there were no sig-
nificant differences in the guanylyltransferase or ATPase activ-
ities of the mutant protein relative to the wild-type protein at
either the permissive or nonpermissive temperature. There was a
slight, but reproducible, decrease (74%) in the RNA triphos-
phatase activity of the mutant relative to the wild-type protein
at the nonpermissive temperature. The specific effect on RNA
triphosphatase activity suggests that L105 may be part of the
RNA binding site. RNA triphosphatase and ATPase activities
map to the same active site; therefore, L105 is probably not
part of the catalytic site, as the mutation affected only one of
the activities.
More extensive thermal inactivation profiles showed that the
thermal stability of L105F was equivalent to that of the wild
type at permissive and nonpermissive temperatures. However,
the guanylyltransferase and RNA triphosphatase activities of
L105F were more sensitive than wild-type activities to pro-
longed incubation at 37°C, although the ATPase activities were
equivalent at this temperature. Thus, differences were only
seen at temperatures which are not physiologically relevant.
Further experimentation will be required to determine wheth-
er the phenotype of the L105F mutant is due to a defect in
mRNA capping. A decrease in RNA triphosphatase activity is
unlikely to result in a ts phenotype. It is well established that in
the vaccinia virus system the rate of gamma phosphate hydro-
lysis greatly exceeds the rate of cap formation (39). RNAs with
triphosphate ends are efficiently capped by the vaccinia virus
capping enzyme (45), but it is unlikely that the resulting tetra-
phosphate caps would be efficiently translated. Therefore, sig-
nificant differences in the activities of the two enzymes are
required to ensure that guanylyltransferase never encounters a
triphosphate end, thus preventing the formation of tetraphos-
phate cap structures. We cannot directly measure the relative
rates of RNA triphosphatase and capping in LEF-4, because
the enzyme is not active in the transfer of GMP to RNA.
However, it seems reasonable to assume that the baculovirus
enzyme is also much more active in hydrolysis than in guany-
lyltransferase. And if this is true, a 74% decrease in triphos-
phatase probably would not significantly alter the formation of
triphosphate caps. Furthermore, even if 74% of the late RNAs
were not capped or were incorrectly capped, the result would
probably not be a lethal phenotype but instead merely a slight
reduction in the synthesis of late viral proteins.
Comparison of the sequences surrounding L105 with se-
quences of the poxvirus capping enzymes or African swine
fever virus capping enzyme did not reveal any sequence simi-
larity in this region. This finding is consistent with our conclu-
sions that L105 is not part of the active site of the enzyme and
raises the possibility that substitution of phenylalanine, which
has a large aromatic ring, destabilizes the interactions between
the RNA polymerase subunits. Development of a reconstitu-
tion system for the baculovirus RNA polymerase should help
to answer this question.
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